Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Jenner

Showing results (1-10 of 548) with videos related to

Pageof 55
Sort By:
Parkinsonism & Related Disorders|July 2, 2008
Genetic susceptibility and the occurrence of Parkinson's diseaseP Jenner
Pathologie-Biologie|January 1, 1996
Oxidative stress in Parkinson's disease and other neurodegenerative disordersP Jenner
Neurology|March 1, 1995
The rationale for the use of dopamine agonists in Parkinson's diseaseP Jenner
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Oxidative mechanisms in nigral cell death in Parkinson's diseaseP Jenner
Journal of Neural Transmission. Supplementum|January 1, 1993
Presymptomatic detection of Parkinson's diseaseP Jenner
Human & Experimental Toxicology|August 1, 1996
Hidden persuasionP Jenner
Acta Neurologica Scandinavica. Supplementum|January 1, 1991
Oxidative stress as a cause of Parkinson's diseaseP Jenner
Annals of Neurology|April 13, 2000
Factors influencing the onset and persistence of dyskinesia in MPTP-treated primatesP Jenner
Lancet (London, England)|September 17, 1994
Oxidative damage in neurodegenerative diseaseP Jenner
Acta Neurologica Scandinavica. Supplementum|January 1, 1993
Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's diseaseP Jenner
Pageof 55

Showing results (1-10 of 548) with videos related to

Sort By:
Pageof 55
Parkinsonism & Related Disorders|July 2, 2008
Genetic susceptibility and the occurrence of Parkinson's diseaseP Jenner
Pathologie-Biologie|January 1, 1996
Oxidative stress in Parkinson's disease and other neurodegenerative disordersP Jenner
Neurology|March 1, 1995
The rationale for the use of dopamine agonists in Parkinson's diseaseP Jenner
Movement Disorders : Official Journal of the Movement Disorder Society|June 5, 1998
Oxidative mechanisms in nigral cell death in Parkinson's diseaseP Jenner
Journal of Neural Transmission. Supplementum|January 1, 1993
Presymptomatic detection of Parkinson's diseaseP Jenner
Human & Experimental Toxicology|August 1, 1996
Hidden persuasionP Jenner
Acta Neurologica Scandinavica. Supplementum|January 1, 1991
Oxidative stress as a cause of Parkinson's diseaseP Jenner
Annals of Neurology|April 13, 2000
Factors influencing the onset and persistence of dyskinesia in MPTP-treated primatesP Jenner
Lancet (London, England)|September 17, 1994
Oxidative damage in neurodegenerative diseaseP Jenner
Acta Neurologica Scandinavica. Supplementum|January 1, 1993
Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's diseaseP Jenner
Pageof 55